Lab Corp. (LH) Receives FDA Emergency Use Authorization for COVID-19 Sample Pooling
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Lab Corp. (LH) Tops Q2 EPS by $1.58, Revenues Beat
July 28, 2020 6:51 AM EDTLab Corp. (NYSE: LH) reported Q2 EPS of $2.57, $1.58 better than the analyst estimate of $0.99. Revenue for the quarter came in at $2.8 billion versus the consensus estimate of $2.5 billion.
Q2 revenue of $2.8 billion, down (4%) from $2.9 billion last yearQ2 diluted EPS of $2.37, up 23% from $1.93 last year; Q2 adjusted EPS of $2.57, down (12%) from $2.93 last yearQ2 free cash flow of $272 million, up from $168 million last yearProcessed more than 8.5 million molecular COVID-19 tests to date, increased capacity to approximately 180 thousand tests per day, and delivering results on average in 2 to 3 days with faster results for hospitalized... More